CytomX Therapeutics (CTMX) PT Lowered to $8 at BTIG
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Price: $3.67 --0%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Join SI Premium – FREE
BTIG analyst Kaveri Pohlman lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $8.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
- Medtronic, Inc. (MDT) PT Raised to $104 at Wells Fargo
- Unicaja (UNI:SM) PT Raised to EUR2.80 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
